SHINE Technologies

About:

SHINE Technologies develops fusion technology to inspect industrial components, produce medical isotopes, and generate fusion energy.

Website: https://www.shinefusion.com

Twitter/X: shinefusion

Top Investors: Alumni Ventures, National Science Foundation, US Department of Energy, Fidelity, Deerfield

Description:

SHINE deploys its safe, cost-effective, and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy, and other sectors. SHINE’s proprietary medical isotope production processes create molybdenum-99 and non-carrier-added lutetium-177. These important medicines are used in tens of thousands of daily procedures to diagnose and treat heart disease, late-stage cancer, and other serious illnesses. In the future, SHINE plans to scale its fusion technology to help solve one of the energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth.

Total Funding Amount:

$774M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Janesville, Wisconsin, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)shinefusion.com

Founders:

Gregory Piefer

Number of Employees:

251-500

Last Funding Date:

2024-10-17

IPO Status:

Private

© 2025 bioDAO.ai